1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy.

Min Kyeong KimHye Seung JungSoo Heon KwakYoung Min ChoKyong Soo ParkSeong Yeon Kim

Published in: Endocrinology and metabolism (Seoul, Korea) (2016)

1,5-AG level was negatively associated with hypoglycemia score determined by recall and with documented hypoglycemia after adjusting for mean glucose and duration of insulin treatment. As a result, this level could be a marker of the risk of hypoglycemia in patients with well-controlled T2DM receiving insulin therapy.

Keyphrases

type diabetes
glycemic control
blood glucose
insulin resistance
weight loss
stem cells
adipose tissue
cell therapy
highly efficient